About PT-141
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide derived from the melanocortin-4 receptor system, originally developed from the research compound Melanotan II. This peptide demonstrates selective binding affinity for melanocortin receptors MC3R and MC4R in preclinical models. Our Stroid UK Shop supplies PT-141 as a 10mg lyophilised powder for in-vitro laboratory investigation of melanocortin pathways and associated physiological mechanisms.
Laboratory Research Applications
Scientists investigate PT-141 for its unique mechanism of action through central melanocortin receptor activation rather than vascular pathways. Research models demonstrate that this peptide bypasses traditional nitric oxide-dependent mechanisms, making it valuable for comparative studies with other compounds. Laboratories examining PT-141 bremelanotide research often analyse its effects on hypothalamic-pituitary pathways and melanocortin signalling cascades. The compound’s cyclic structure provides enhanced stability compared to linear peptide analogues, facilitating extended research protocols. Studies frequently compare PT-141 with other peptide research compounds available through our peptide research category to examine differential receptor binding profiles.
Technical Specifications
| Parameter | Value |
|---|---|
| Compound Name | PT-141 (Bremelanotide) |
| CAS Number | 189691-06-3 |
| Molecular Formula | C50H68N14O10 |
| Molecular Weight | 1025.16 g/mol |
| Form | Lyophilised powder |
| Quantity | 10mg per vial |
| Storage | -20°C (powder), 2-8°C (reconstituted) |
Research institutions studying melanocortin biology often combine PT-141 investigations with broader selective androgen receptor modulator research to examine crosstalk between different signalling pathways. The compound’s well-characterised receptor binding profile makes it suitable for competitive binding assays and structure-activity relationship studies in melanocortin research.
Compliance Statement
PT-141 10mg Beligas is supplied strictly for in-vitro research purposes only. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must comply with institutional guidelines and local regulations when handling this research compound. All peptide research should be conducted by qualified personnel in appropriate laboratory facilities with proper safety protocols.
